Clinical Trial Update: Study of Oglemilast for the Treatment of Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oglemilast for asthma has completed enrollment and follow-up. The update does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Oglemilast (oglemilast)

Snippet

Sponsor: Forest Laboratories | Conditions: Asthma | Phase 2 | Status: COMPLETED